Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page

ViewFlex Xtra Intracardiac Echocardiography catheter gets FDA clearance

Tuesday, 10 Jul 2012 15:08
ViewFlex Xtra ICE catheter
ViewFlex Xtra ICE catheter

The US Food and Drug Administration (FDA) has given 510(k) clearance to St Jude Medical to market its ViewFlex Xtra Intracardiac Echocardiography (ICE) catheter. This new technology is designed to be used with the ViewMate Z Ultrasound console, a system that provides fast, clear images to help visualise cardiac structures and blood flow within the heart during complex electrophysiology or interventional procedures.

The images produced by the ViewFlex Xtra ICE catheter and the ViewMate Z Ultrasound console help physicians confirm the location of cardiac structures and blood flow during procedures such as radiofrequency ablation to treat arrhythmias and structural heart procedures to close atrial septal defects.

The ViewFlex ICE catheter has an ergonomic handle allowing for single handed, four-way tip deflection and self-locking steering. The new handle helps streamline procedures by providing increased maneuverability with the potential to minimise catheter repositioning.

“The ViewFlex Xtra catheter offers an advancement to the ViewMate Z Ultrasound console through its four-way tip deflection, a feature that allows physicians to more easily obtain desired viewing angles of the cardiac anatomy,” said Dhanunjay Lakkireddy, professor of Medicine and director of the Center for Excellence in Atrial Fibrillation and EP Research from the University of Kansas Medical Center in Kansas City, USA, who first used the new ViewFlex Xtra ICE Catheter. “The wide range of viewing options and high-quality images allow me to focus more on the patient and less on the catheter.”

Add New Comment

Most popular

Tuesday, 12 Aug 2014
Toshiba has announced that it will feature SURESubtraction Coronary at The European Society of Cardiology (ESC) congress (30 August–3 September, Barcelona, Spain). Toshiba Introduces SURESubtraction Coronary at ESC 2014

Friday, 22 Aug 2014
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration to market its precision planning application for transcatheter aortic-valve implantation (TAV... FDA 510(k) clearance for TAVI precision treatment planning application

CE mark approval for Agent drug-coated balloon
Friday, 25 Jul 2014
According to Boston Scientific, the Agent drug-coated balloon provides physicians with an additional alternative to treat both in-stent restenosis and de novo small vessel coronary disease. CE mark approval for Agent drug-coated balloon


Drug-coated balloons for the management of coronary artery disease
Thursday, 04 Sep 2014
Robert Byrne writes that although drug-coated balloon therapy has been a significant innovation with relevance for everyday practice, convincing data in the coronary arena exists thus far only for ... Drug-coated balloons for the management of coronary artery disease

Transitioning from transfemoral to transradial: Why the transradial approach is here to stay
Thursday, 21 Aug 2014
William H Crowder believes that, despite some US interventional cardiologists’ reluctance to use the approach, the transradial approach will become standard of care for coronary catheterisation ... Transitioning from transfemoral to transradial: Why the transradial approach is here to stay


David J Cohen
Wednesday, 04 Jun 2014
David J Cohen, director, Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas C... David J Cohen

Ashok Seth
Wednesday, 12 Feb 2014
Ashok Seth is the immediate past president of Cardiological Society of India and is the principal ... Ashok Seth

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions